Company Expansion - The Joint Corp opened its first clinic in San Francisco, located at 1549-A Sloat Blvd in Lakeshore Plaza [1] - This is the second location for franchisee Jacki Walker, who previously opened a clinic in Daly City in April [1] Franchise Strategy - The company aims to meet patients' healthcare needs by expanding into diverse and busy communities [2] - Franchise partners like Jacki Walker are crucial for the company's coast-to-coast growth [2] Franchisee Background - Jacki Walker has experience with another health and wellness franchise in Walnut Creek and Menlo Park [3] - She chose to bring The Joint to San Francisco due to the area's underserved chiropractic care market [3] Service Model - The Joint Chiropractic offers convenient, affordable care without appointments or insurance hassles [4] - The clinics operate with accommodating hours, including evenings and weekends [4] Company Overview - The Joint Corp is the largest operator, manager, and franchisor of chiropractic clinics in the US [5] - The company has over 950 locations nationwide and serves more than 13 million patients annually [5] - It introduced a retail healthcare business model in 2010, revolutionizing access to chiropractic care [5] Business Structure - The Joint Corp operates as a franchisor and clinic operator in multiple states across the US [6] - The company and its franchisees provide management services to affiliated chiropractic practices in 22 states and the District of Columbia [6]

The Joint Corp. (NASDAQ:JYNT) Q2 2024 Earnings Conference Call August 8, 2024 5:00 PM ET Company Participants David Barnard - LHA Investor Relations Peter Holt - President and Chief Executive Officer Jake Singleton - Chief Financial Officer Conference Call Participants JP Wollam - ROTH Capital Partners C.J. Dipollino - Craig Hallum Capital Group Nick Sherwood - Maxim Group Operator Good day, and welcome to the Joint Corporation, Second Quarter of 2024 Financial Results Conference Call. All participants will ...

The Joint Corp. (JYNT) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to loss of $0.01 per share a year ago. These figures are adjusted for nonrecurring items. This quarterly report represents an earnings surprise of -500%. A quarter ago, it was expected that this company would post a loss of $0.03 per share when it actually produced earnings of $0.06, delivering a surprise of 300%. Over the last four quarters, the company has surpasse ...

. Alternus Clean Energy and Hover Energy Announce Exciting New Joint Venture to Deliver Next Generation Microgrid Solutions to Data Centers and Corporate Customers Microgrid Market forecast to reach over $100 Billion by 2032 August 08, 2024 8:00 AM EDT | Source: Alternus Clean Energy Inc. Fort Mill, South Carolina--(Newsfile Corp. - August 8, 2024) - Alternus Clean Energy (Nasdaq: ALCE) ("Alternus"), a transatlantic independent clean energy producer, and Hover Energy ("Hover"), a leading international micro ...

BRISBANE, Australia, Aug. 08, 2024 (GLOBE NEWSWIRE) -- NOVONIX Limited (NASDAQ: NVX, ASX: NVX) ("NOVONIX" or "the Company"), a leading battery materials and technology company, and CBMM, the world leader in the production and commercialization of niobium products, have announced the signing of a joint development agreement focused on nickel-based cathode materials. Under the agreement, NOVONIX will use its patented all-dry, zero-waste synthesis process to synthesize, test, and analyze cathode active materia ...

TORONTO, Aug. 6, 2024 /PRNewswire/ - AGEDB Technology Ltd. ("AGEDB" or the "Company") (TSXV: AGET), a leading provider of graph database software and services, today announced a strategic joint R&D agreement with Ovation Solutions Inc. and Bitnine co., Ltd. This collaboration aims to integrate AGEDB's Apache AGE-based graph database and Bitnine's AgensSQL GenAI into Microsoft Azure Stack Hub, significantly enhancing its capabilities for enterprise customers. Key Highlights of the Agreement: Joint R&D: As a ...

Collaboration to Leverage ImmunoForge's ELP Platform Technology Which Can Increase the Half-Life of a Drug by up to 200 Times CAMBRIDGE, Mass., Aug. 6, 2024 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that it has signed a joint research agreement, together with Dong-A ST Co. Ltd. and ImmunoForge, to develop a long-acting, once-monthly, formulation of DA-1726, a novel, dual oxyntomodulin ...

IRVING, Texas, July 31, 2024 /PRNewswire/ -- Darling Ingredients Inc. (NYSE: DAR), the world's leading company turning food waste into sustainable products and producer of renewable energy, today announced that its 50/50 joint venture Diamond Green Diesel (DGD) will provide the first regular supply of neat sustainable aviation fuel (SAF), to be blended with conventional jet fuel to create blended SAF, for commercial air travel out of John F. Kennedy International Airport (JFK) to begin in the next few month ...

The Tariki Joint Venture has agreed to sell to the Offtaker 2 petajoules of gas, approximately 1.8bcf to be produced from the Tariki-5 well; The Tariki Joint Venture has agreed that, for a period of 12 months after Tariki-5 well has been drilled and evaluated, to work exclusively with the Offtaker to negotiate the terms and conditions for the storage of gas in the Tariki field; In consideration for granting the exclusive right described above, the Offtaker has agreed to pay NZ$2,000,000 to the Tariki Joint ...

SCOTTSDALE, Ariz., July 25, 2024 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, announced it will report its second quarter 2024 financial results on Thursday, August 8, 2024, after the market close. President and CEO Peter D. Holt and CFO Jake Singleton will hold a conference call at 5:00 p.m. EDT that day to discuss the results. Shareholders and interested participants may listen to a live broadcast of the con ...